Early ‘Scattershot’ Approach To COVID-19 Therapeutic Research Generated Little Actionable Data

 
• By Sue Sutter
  
Telephone wire mess
Early clinical research on COVID therapeutics was disjointed and likely to yield little useful data, an FDA analysis found. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D